» Articles » PMID: 25210958

Risk Factors for Death in Patients with Severe Asthma

Overview
Journal J Bras Pneumol
Specialty Pulmonary Medicine
Date 2014 Sep 12
PMID 25210958
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify risk factors for death among patients with severe asthma.

Methods: This was a nested case-control study. Among the patients with severe asthma treated between December of 2002 and December of 2010 at the Central Referral Outpatient Clinic of the Bahia State Asthma Control Program, in the city of Salvador, Brazil, we selected all those who died, as well as selecting other patients with severe asthma to be used as controls (at a ratio of 1:4). Data were collected from the medical charts of the patients, home visit reports, and death certificates.

Results: We selected 58 cases of deaths and 232 control cases. Most of the deaths were attributed to respiratory causes and occurred within a health care facility. Advanced age, unemployment, rhinitis, symptoms of gastroesophageal reflux disease, long-standing asthma, and persistent airflow obstruction were common features in both groups. Multivariate analysis showed that male gender, FEV1 pre-bronchodilator < 60% of predicted, and the lack of control of asthma symptoms were significantly and independently associated with mortality in this sample of patients with severe asthma.

Conclusions: In this cohort of outpatients with severe asthma, the deaths occurred predominantly due to respiratory causes and within a health care facility. Lack of asthma control and male gender were risk factors for mortality.

Citing Articles

SIRT5 Alleviated Eosinophilic Asthma Through ROS Inhibition and Nrf2/HO-1 Activation.

Xie Y, He Y, Liang J, Liu J, Ke C, Mo X Inflammation. 2025; .

PMID: 39946006 DOI: 10.1007/s10753-025-02257-w.


Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US.

Bogart M, Germain G, Laliberte F, Mahendran M, Duh M, DiRocco K J Asthma Allergy. 2023; 16:1309-1322.

PMID: 38058516 PMC: 10697089. DOI: 10.2147/JAA.S424055.


Severe Acute Bronchial Asthma with Sepsis: Determining the Status of Biomarkers in the Diagnosis of the Disease.

Sinha S, Kumar S, Narwaria M, Singh A, Haque M Diagnostics (Basel). 2023; 13(16).

PMID: 37627950 PMC: 10453001. DOI: 10.3390/diagnostics13162691.


Estimating medication adherence from Electronic Health Records: comparing methods for mining and processing asthma treatment prescriptions.

Tibble H, Sheikh A, Tsanas A BMC Med Res Methodol. 2023; 23(1):167.

PMID: 37438684 PMC: 10337150. DOI: 10.1186/s12874-023-01935-3.


Determinants of Asthma Attack Among Adult Asthmatic Patients Attending at Public Hospitals of West Shoa Zone, Oromia Regional State, Ethiopia, 2021: Case-Control Study.

Megersa S, Chala G, Fikremariam K J Asthma Allergy. 2022; 15:1143-1154.

PMID: 36042713 PMC: 9420415. DOI: 10.2147/JAA.S376499.


References
1.
Masoli M, Fabian D, Holt S, Beasley R . The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004; 59(5):469-78. DOI: 10.1111/j.1398-9995.2004.00526.x. View

2.
Hansen E, Vestbo J, Phanareth K, Kok-Jensen A, Dirksen A . Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163(3 Pt 1):690-3. DOI: 10.1164/ajrccm.163.3.2006120. View

3.
Rodrigo G, Rodrigo C, Hall J . Acute asthma in adults: a review. Chest. 2004; 125(3):1081-102. DOI: 10.1378/chest.125.3.1081. View

4.
Ryan G, Knuiman M, Divitini M, James A, Musk A, Bartholomew H . Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health. 1999; 53(4):230-4. PMC: 1756854. DOI: 10.1136/jech.53.4.230. View

5.
James A, Elliot J, Abramson M, Walters E . Time to death, airway wall inflammation and remodelling in fatal asthma. Eur Respir J. 2005; 26(3):429-34. DOI: 10.1183/09031936.05.00146404. View